Is VHT a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The case for VHT is simple: low-cost, diversified exposure to MSCI US Investable Market Health Care 25/50 Index at a 0.09% expense ratio, anchored by names like LLY, JNJ, ABBV. If that is the exposure you want and you do not already own most of it through another fund, VHT is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want MSCI US Investable Market Health Care 25/50 Index and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with VHT?
VHT tracks the MSCI US Investable Market Health Care 25/50 Index at a 0.09% expense ratio, holding more than 400 US health-care stocks across the market-cap spectrum. It is led by Eli Lilly, Johnson & Johnson, AbbVie, and Merck. The key nuance versus XLV: VHT owns roughly seven times as many stocks, reaching deep into mid and small caps, while XLV is limited to the S&P 500 health-care members.
Largest holdings (approximate as of mid-2026; verify on Vanguard's fund page):
What's the case for VHT?
VHT is the Vanguard Health Care ETF, tracking the MSCI US Investable Market Health Care 25/50 Index at a 0.09% expense ratio. It holds more than 400 US health-care stocks across pharma, biotech, insurers, devices, and life-science tools, led by Eli Lilly, Johnson & Johnson, AbbVie, and Merck. Compared with State Street's XLV, which owns only the ~60 health-care names in the S&P 500, VHT reaches far deeper into mid and small caps while still being anchored by the same mega-cap drugmakers. Its yield near 1.5% reflects a growth-tilted sector rather than a pure income play.
In its favour: it gives you MSCI US Investable Market Health Care 25/50 Index exposure in one ticker at a 0.09% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying VHT?
- Cost vs alternatives: 0.09% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of VHT sits in its largest holdings (LLY, JNJ, ABBV).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: VHT only gives you MSCI US Investable Market Health Care 25/50 Index; it will not capture what sits outside that index.
How do you decide if VHT is a buy?
The useful question is rarely “will VHT go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how VHT would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on VHT
The bottom line: VHT is a low-cost core building block for MSCI US Investable Market Health Care 25/50 Index exposure, not a tactical bet on a single name. If you want MSCI US Investable Market Health Care 25/50 Index exposure and the 0.09% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
Build a portfolio around VHT with Walnut
Use VHT as your core holding, then let Walnut's AI propose thematic satellites: AI infrastructure, dividend growth, clean energy, whatever you believe in. Connect your broker, build the basket in conversation, track it as one unit.
FAQ
Is VHT a good ETF to buy?
+
Walnut is informational, not investment advice. Whether VHT fits depends on your goals, time horizon, and what you already hold. It tracks MSCI US Investable Market Health Care 25/50 Index at a 0.09% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does VHT actually hold?
+
VHT tracks MSCI US Investable Market Health Care 25/50 Index. Its largest positions include LLY, JNJ, ABBV, MRK, UNH and others (approximate, verify on Vanguard's fund page). The holdings are what you are really buying, not the ticker.
What is VHT's expense ratio?
+
0.09% as of mid-2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does VHT pay a dividend?
+
VHT distributes a dividend with an approximate yield of ~1.5% (mid-2026). See the VHT dividend page for how distributions work. Verify the current figure with Vanguard.
What are the risks of buying VHT?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether MSCI US Investable Market Health Care 25/50 Index matches the exposure you actually want. VHT only gives you MSCI US Investable Market Health Care 25/50 Index, not what sits outside it.
How do I decide if VHT is right for me?
+
Start from your goal, then check four things: what VHT holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to mid-2026; verify current data with Vanguard or your broker. Nothing here is a recommendation to buy, sell, or hold any security.